Address
Email address
Phone number
Website
https://www.safetoact.comHome | SafeToAct Ltd.We are an Estonian medical device start-up dedicated to developing high fidelity kidney replicas. Our mission is to improve patient healthcare by allowing physicians to train in a safe and controlled environment.
Name
OÜ SafeToAct
Registry code
12612926
VAT number
EE101765147
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
12.02.2014 (12)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72101 -
800 €
-60 €
-8%
-
9 417 €
0
Submitted
No tax arrears
-1%
-1%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Maarja Kruusmaa
| 39% - 975.00 EUR | - | Direct ownership |
| Omanikukonto: SIIM KRUUSMAA
| 39% - 975.00 EUR | - | Other control or influence (contractual, family or other relationships) |
| Peeter Ross
| 35% - 887.00 EUR | Board member | Direct ownership |
| Omanikukonto: ASKO RISTOLAINEN
| 26% - 638.00 EUR | Board member | Direct ownership |
| 2019 26.08.2020 | 2020 30.06.2021 | 2021 05.07.2022 | 2022 30.06.2023 | 2023 01.07.2024 | 2024 30.06.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 18 900 € | 8 550 € | 1 750 € | 1 583 € | 1 400 € | 800 € |
| Net profit (loss) for the period | 14 903 € | 4 193 € | 267 € | 280 € | -229 € | -60 € |
| Profit Margin | 79% | 49% | 15% | 18% | -16% | -8% |
| Current Assets | 26 633 € | 7 234 € | 7 375 € | 8 436 € | 8 976 € | 9 607 € |
| Fixed Assets | 3 589 € | 2 820 € | 2 051 € | 1 282 € | 513 € | 0 € |
| Total Assets | 30 222 € | 10 054 € | 9 426 € | 9 718 € | 9 489 € | 9 607 € |
| Current Liabilities | 25 256 € | 895 € | 0 € | 12 € | 12 € | 190 € |
| Non Current Liabilities | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - |
| Share Capital | - | - | - | - | - | - |
| Equity | 4 966 € | 9 159 € | 9 426 € | 9 706 € | 9 477 € | 9 417 € |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 0 € | - | - | - |
| 2025 Q3 | 1 400 € | 714 € | 740 € | - |
| 2025 Q2 | 1 350 € | - | - | - |
| 2025 Q1 | 1 319 € | 176 € | 0 € | - |
| 2024 Q4 | 0 € | - | - | - |
| 2024 Q3 | 0 € | 134 € | 140 € | - |
| 2024 Q2 | 0 € | - | - | - |
| 2024 Q1 | 0 € | - | - | - |
| 2023 Q4 | 700 € | - | - | - |
| 2023 Q3 | 908 € | 121 € | 0 € | - |
| 2023 Q2 | 0 € | - | - | - |
| 2023 Q1 | 0 € | - | - | - |
| 2022 Q4 | 0 € | - | - | - |
| 2022 Q3 | 0 € | - | - | - |
| 2022 Q2 | 0 € | - | - | - |
| 2022 Q1 | 1 950 € | 125 € | 0 € | - |
